Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer

@inproceedings{Suh2014EndocrinizationOF,
  title={Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer},
  author={Jae Myoung Suh and Johan W. Jonker and Maryam Ahmadian and Regina M Goetz and Denise E. Lackey and Olivia Osborn and Zifeng Huang and Weilin Liu and Eiji Yoshihara and Theo H. van Dijk and Rick Havinga and Weiwei Fan and Yun-qiang Yin and Ruth T Yu and Christopher Liddle and Annette R. Atkins and Jerrold M. Olefsky and Moosa Mohammadi and Michael Downes and Ronald M Evans},
  booktitle={Nature},
  year={2014}
}
Fibroblast growth factor 1 (FGF1) is an autocrine/paracrine regulator whose binding to heparan sulphate proteoglycans effectively precludes its circulation. Although FGF1 is known as a mitogenic factor, FGF1 knockout mice develop insulin resistance when stressed by a high-fat diet, suggesting a potential role in nutrient homeostasis. Here we show that parenteral delivery of a single dose of recombinant FGF1 (rFGF1) results in potent, insulin-dependent lowering of glucose levels in diabetic mice… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 74 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 45 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 17 references

Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor gamma

  • W Wei
  • Proc Natl Acad Sci U S A
  • 2012

Fibroblast growth factor-21 regulates PPARgamma activity and the antidiabetic actions of thiazolidinediones

  • PA Dutchak
  • 2012

Similar Papers

Loading similar papers…